July 9, 2007- Medtronic Inc. announced the European introduction of the Reveal DX, a new insertable cardiac monitor that offers diagnostic and monitoring information related to syncope (fainting) in patients.
July 10, 2007 โ The Joint Department of Medical Imaging of the University Health Network (UHN) / Mount Sinai Hospital ...
June 9, 2007 - Scivanta Medical Corp. and Ethox International Inc. announced that they entered into an agreement to ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 9, 2007 - Medtronic Inc. announced the commercial launch of its latest cardiac resynchronization therapy ...
July 9, 2007 - Stereotaxis magnetic navigation systems are being used to guide catheters into the heart for repairs. A ...
July 9, 2007 - A study published in the Journal of Nuclear Medicine reports that current PET-CT scanners with standard ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 9, 2007 - Zerusa Limited and Vascular Solutions Inc. announced that they have entered into a distribution agreement ...
July 9, 2007 โ According to The Results for Life Campaign, lab tests for heart attacks enable accurate diagnosis and ...
July 6, 2007 - CardioTech International Inc. announced that it has signed an agreement to sell its Gish Biomedical Inc ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July, 6, 2007 โ Toshiba America Medical Systems, Inc. announced a partnership with CVCTA Education to provide a ...
July 5, 2007 - Agfa HealthCare presented its completely integrated CVIS-radiology PACS with full-featured ...
July 5, 2007 โ Vascular Solutions, Inc. announced that it has received 510(k) clearance from the U.S. Food & Drug ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 5, 2007 โ Covidien Ltd., formerly known as Tyco Healthcare, recently spun off from Tyco International, began ...
July 5, 2007 โ The FDA has cleared Spectranetics Corp. to market its TURBO-Booster product for the treatment of arterial stenoses and occlusions in the leg, a peripheral laser catheter that functions as a guiding catheter facilitating directed ablation of blockages in the main arteries at or above the knee.
July 2, 2007 - New research published in the July issue of the Journal of Vascular Surgery indicates that arterial ...